Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Qualigen Therapeutics Inc (QLGN)

Qualigen Therapeutics Inc (QLGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,359
  • Shares Outstanding, K 38,796
  • Annual Sales, $ 5,650 K
  • Annual Income, $ -17,900 K
  • 60-Month Beta -0.54
  • Price/Sales 1.95
  • Price/Cash Flow N/A
  • Price/Book 0.60
Trade QLGN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.50
  • Most Recent Earnings -0.11 on 08/16/22
  • Next Earnings Date 11/21/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 354.50% ( +64.47%)
  • Historical Volatility 34.48%
  • IV Percentile 52%
  • IV Rank 25.48%
  • IV High 1,190.95% on 09/14/22
  • IV Low 68.46% on 08/16/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 10
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.02
  • Today's Open Interest 648
  • Open Int (30-Day) 1,271

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2595 +4.05%
on 10/03/22
0.3776 -28.50%
on 09/06/22
-0.1094 (-28.84%)
since 09/02/22
3-Month
0.2595 +4.05%
on 10/03/22
0.5300 -49.06%
on 07/06/22
-0.2520 (-48.28%)
since 07/01/22
52-Week
0.2595 +4.05%
on 10/03/22
3.1200 -91.35%
on 11/23/21
-1.0200 (-79.07%)
since 10/01/21

Most Recent Stories

More News
Qualigen Therapeutics Reports Positive QN-247 Readout in Triple Negative Breast Cancer in Vivo Model

CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics Announces Partnership with Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies for QN-302

CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics to Present at BIO International Convention

CARLSBAD, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics Announces IND-Enabling Studies to Advance Lead Program QN-302 Toward Clinical Trials

A Potential Treatment for Pancreatic Cancer in Addition to Other Tumors of High Unmet Clinical Need CARLSBAD, Calif., June 07, 2022 (GLOBE NEWSWIRE)...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex

Transaction expected to significantly advance commercial readiness of NanoSynex’s innovative diagnostics technology platform focused on the $30+ Billion...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics’ Pan-RAS Inhibitor Featured in Two Abstracts at American Society for Clinical Oncology (ASCO) 2022 Annual Meeting

Abstracts Highlight In Vitro and In Vivo Activity of Qualigen’s Pan-RAS inhibitor in (1) Pancreatic Cancer, and (2) Malignant Peripheral Nerve Sheath...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics to Present at the H.C. Wainwright Global Investment Conference

CARLSBAD, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics, Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results

CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics’ Partner NanoSynex to Present Technology at BioMed Israel

Innovative Technology Aims to Accelerate Antimicrobial Susceptibility Test Result Times by Six-Fold CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) --...

QLGN : 0.2700 (+1.12%)
Qualigen Therapeutics to Acquire Majority Stake in Diagnostics Technology Company NanoSynex

Companies to Collaborate in the Development of Innovative Diagnostics Platform to Combat “Superbugs,” a Rising Global Health Crisis CARLSBAD, Calif., May ...

QLGN : 0.2700 (+1.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 0.3007
2nd Resistance Point 0.2903
1st Resistance Point 0.2802
Last Price 0.2700
1st Support Level 0.2597
2nd Support Level 0.2493
3rd Support Level 0.2392

See More

52-Week High 3.1200
Fibonacci 61.8% 2.0273
Fibonacci 50% 1.6897
Fibonacci 38.2% 1.3522
Last Price 0.2700
52-Week Low 0.2595

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar